Trials / Completed
CompletedNCT03795064
Immediate Versus Early Endovenous Ablation In Venous Ulcer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Oulu University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is conducted to assess the effects of immediately started foam sclerotherapy in venous ulcer compared to early intervention.
Detailed description
Recently EVRA study showed that early endovenous ablation (foam sclerotherapy and/or endothermal ablation) is beneficial for venous ulcer healing. This randomized controlled trial is conducted to assess the effects of immediate foam sclerotherapy in the first visit to vascular outpatient clinic (immediate intervention). Patients in control group will receive foam sclerotherapy at four weeks (early intervention). Endothermal ablation is performed in early setting in both groups when truncal vein anatomy is suitable. The primary outcome for this study is the reduction of venous ulcer area at four weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Foam sclerotherapy | Foam sclerotherapy is used to all patients for endovenous ablation of insufficient veins in subulcer plexus area. |
| PROCEDURE | Endothermal ablation | Endothermal ablation is performed in early setting when truncal vein(s) anatomy is suitable. |
Timeline
- Start date
- 2018-12-05
- Primary completion
- 2023-01-30
- Completion
- 2023-08-30
- First posted
- 2019-01-07
- Last updated
- 2024-04-03
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT03795064. Inclusion in this directory is not an endorsement.